Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development

Molecular and Cellular Biology

Volumn 22, Issue 20, 2002, Pages 7291-7301

  González Suárez, Eva ^a   Flores, Juana M ^a   Blasco, María A ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TELOMERASE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENOTYPE; LIFESPAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC CELL; TRANSGENE;

ANIMALS; DATA INTERPRETATION, STATISTICAL; DNA-BINDING PROTEINS; GENE EXPRESSION; INCIDENCE; LYMPHOID TISSUE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTAGENESIS; NEOPLASMS; PRECANCEROUS CONDITIONS; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0036787840     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.20.7291-7301.2002     Document Type: Article

References (33)

1. Bednarek, A. K., Y. Chu, T. J. Slaga, and C. Aldaz. 1997. Telomerase and cell proliferation in mouse skin papillomas. Mol. Carcinog. 20:329-331.
2. Blackburn, E. H. 1991. Structure and function of telomeres. Nature 350: 569-573.
3. Blasco, M. A., M. Rizen, C. W. Greider, and D. Hanahan. 1996. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat. Genet. 12:200-204.
4. Blasco, M. A., H.-W. Lee, P. Hande, E. Samper, P. Lansdorp, R. DePinho, and C. W. Greider. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34.
5. Bodnar, A. G., M. Ouellette, M. Frolkis, et al. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
6. a.Broccoli, D., L. A. Godley, L. A. Donehower, H. E. Varmus, and T. de Lange. 1996. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16:3765-3772.
7. b. Chan, S.W.-L., and E. H. Blackburn. 2002. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene 21:553-563.
8. Chin, L., S. E. Artandi, Q. Shen, et al. 1999. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97:527-538.
9. Collins, K. 2000. Mammalian telomeres and telomerase. Curr. Opin. Cell Biol. 12:378-383.
10. Donehower, L. A., M. Harvey, B. L. Slagle, et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
11. González-Suárez, E., E. Samper, J. M. Flores, and M. A. Blasco. 2000. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 26:114-117.
12. González-Suarez, E., E. Samper, A. Ramírez, J. Flores, J. Martín-Caballero, J. L. Jorcano, and M. A. Blasco. 2001. Increased epidermal tumors and increased skin, wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20:2619- 2630.
13. Goytisolo, F. A., and M. A. Blasco. 2002. Many ways to telomere dysfunction. In vivo studies with mouse models. Oncogene 21:584-591.
14. D2/3 cancer-prone mouse. Cell 97:515-525.
15. Hahn, W. C., C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks, and R. A. Weinberg. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464-468.
16. Harley, C. B., A. B. Futcher, and C. W. Greider. 1990. Telomeres shorten during ageing of human fibroblasts. Nature 31:458-460.
17. Harvey, M., M. J. McArthur, C. A. Montgomery, Jr., J. S. Butel, A. Bradley, and L. A. Donehower. 1993. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet. 5:225-229.
18. Hemann, M. T., M. A. Strong, L. Y. Hao, and C. Greider. 2001. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107:67-77.
19. Jacks, T., L. Remington, B. O. Williams, et al. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1-7.
20. Jiang, X.-R., G. Jimenez, E. Chang, et al. 1999. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21:111-114.
21. Lee, H.-W., M. A. Blasco, G. J. Gottlieb, J. W. Horner, C. W. Greider, and R. A. DePinho. 1998. Essential role of mouse telomerase in highly proliferative organs. Nature 392:569-574.
22. a.Mattson, M. P., W. Fu, and P. Zhang. 2001. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective Mech. Aging Dev. 122:659-671.
23. Mitchell, J. R., E. Wood, and K. Collins. 1999. A telomerase component is defective in the human disease dyskeratosis congenital. Nature 402:551-555.
24. Morales, C. P., S. E. Holt, M. Ouellette, et al. 1999. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21:115-118.
25. Murillas, R., F. Larcher, C. J. Conti, M. Santos, A. Ullrich, and J. L. Jorcano. 1995. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations on hair follicle development and skin structure. EMBO J. 14: 5216-5223.
26. Nugent, C. I., and V. Lundblad. 1998. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12:1073-1085.
27. Oh, H., G. E. Taffet, K. A. Youker, et al. 2001. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl. Acad. Sci. USA 98:10308-10313.
28. Rudolph, K. L., S. Chang, H.-W. Lee, M. Blasco, G. Gottlieb, W. C. Greider, and R. A. DePinho. 1999. Longevity, stress response, and cancer in aging telomerase deficient mice. Cell 96:701-712.
29. Rudolph, K. L., M. Millard, M. W. Bosenberg, and R. A. De Pinho. 2001. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28:155-159.
30. -/- mice with short telomeres. EMBO Rep. 2:800-807.
31. Shay, J. W., and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer 33:787-791.
32. Wang, J., G. J. Hannon, and D. H. Beach. 2000. Risky immortalization by telomerase. Nature 405:755-756.
33. Wyllie, F. S., C. J. Jones, J. W. Skinner, et al. 2000. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24:16-17.